tiprankstipranks
Thermo Fisher Scientific (TMO)
NYSE:TMO
US Market
TMO
Thermo Fisher
RESEARCH TOOLSreports
Want to see TMO full AI Analyst Report?

Thermo Fisher (TMO) Stock Forecast & Price Target

5,229 Followers
See the Price Targets and Ratings of:

TMO Analyst Ratings

Strong Buy
21Ratings
Strong Buy
16 Buy
5 Hold
0 Sell
Based on 21 analysts giving stock ratings to
Thermo
Fisher
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TMO Stock 12 Month Forecast

Average Price Target

$587.44
▲(11.55% Upside)
Based on 21 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is $587.44 with a high forecast of $650.00 and a low forecast of $490.00. The average price target represents a 11.55% change from the last price of $526.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"418":"$418","651":"$651","476.25":"$476.3","534.5":"$534.5","592.75":"$592.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":650,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$650.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":587.4444444444445,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$587.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":490,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$490.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[418,476.25,534.5,592.75,651],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,513.33,523.843076923077,534.3561538461539,544.8692307692309,555.3823076923077,565.8953846153846,576.4084615384616,586.9215384615385,597.4346153846154,607.9476923076924,618.4607692307693,628.9738461538461,639.4869230769231,{"y":650,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,513.33,519.0311111111112,524.7322222222223,530.4333333333334,536.1344444444445,541.8355555555556,547.5366666666666,553.2377777777778,558.9388888888889,564.64,570.3411111111111,576.0422222222222,581.7433333333333,{"y":587.4444444444445,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,513.33,511.53538461538466,509.7407692307693,507.9461538461539,506.1515384615385,504.3569230769231,502.56230769230774,500.7676923076923,498.9730769230769,497.17846153846153,495.38384615384615,493.58923076923077,491.7946153846154,{"y":490,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":419.939,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":461.358,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":490.93,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":529.276,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":565.836,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":583.547,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":578.298,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":580.613,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":507.568,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":494.044,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":468.74,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":493.545,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":513.33,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$650.00Average Price Target$587.44Lowest Price Target$490.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on TMO
Brandon Couillard
Wells Fargo
Wells Fargo
$615
Buy
16.79%
Upside
Reiterated
07/14/26
Thermo Fisher (TMO) Gets a Buy from Wells Fargo
Morgan Stanley Analyst forecast on TMO
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$620
Buy
17.74%
Upside
Reiterated
07/10/26
Morgan Stanley Keeps Their Buy Rating on Thermo Fisher (TMO)
Deutsche Bank Analyst forecast on TMO
Justin Bowers
Deutsche Bank
Deutsche Bank
$630
Buy
19.64%
Upside
Reiterated
07/09/26
Thermo Fisher named short-term buy idea at Deutsche BankThermo Fisher named short-term buy idea at Deutsche Bank
Evercore ISI Analyst forecast on TMO
Vijay Kumar
Evercore ISI
Evercore ISI
$575→$570
Buy
8.24%
Upside
Reiterated
07/06/26
Thermo Fisher price target lowered to $570 from $575 at Evercore ISIThermo Fisher price target lowered to $570 from $575 at Evercore ISI
Bernstein Analyst forecast on TMO
Eve Burstein
Bernstein
Bernstein
$520
Hold
-1.25%
Downside
Initiated
06/25/26
Thermo Fisher resumed with a Market Perform at BernsteinThermo Fisher resumed with a Market Perform at Bernstein
Barclays Analyst forecast on TMO
Luke Sergott
Barclays
Barclays
$625
Buy
18.69%
Upside
Reiterated
06/24/26
Barclays Sticks to Their Buy Rating for Thermo Fisher (TMO)
William Blair Analyst forecast on TMO
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
06/12/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Piper Sandler Analyst forecast on TMO
David Westenberg
Piper Sandler
Piper Sandler
$510
Hold
-3.15%
Downside
Initiated
06/11/26
Thermo Fisher initiated with a Neutral at Piper SandlerThermo Fisher initiated with a Neutral at Piper Sandler
HSBC Analyst forecast on TMO
Sidharth Sahoo
HSBC
HSBC
$670→$540
Hold
2.54%
Upside
Downgraded
06/03/26
Thermo Fisher downgraded to Hold from Buy at HSBCThermo Fisher downgraded to Hold from Buy at HSBC
Bank of America Securities Analyst forecast on TMO
Michael Ryskin
Bank of America Securities
Bank of America Securities
$630
Buy
19.64%
Upside
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Thermo Fisher (NYSE: TMO)
Wolfe Research Analyst forecast on TMO
Michael Polark
Wolfe Research
Wolfe Research
$535
Buy
1.60%
Upside
Initiated
06/01/26
Thermo Fisher assumed with an Outperform at Wolfe ResearchThermo Fisher assumed with an Outperform at Wolfe Research
Jefferies Analyst forecast on TMO
Tycho Peterson
Jefferies
Jefferies
$650
Buy
23.43%
Upside
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), Thermo Fisher (NYSE: TMO) and Eli Lilly & Co (NYSE: LLY)
Stifel Nicolaus Analyst forecast on TMO
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$600
Buy
13.94%
Upside
Reiterated
05/21/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT), BioMarin Pharmaceutical (NASDAQ: BMRN) and Thermo Fisher (NYSE: TMO)
TD Cowen Analyst forecast on TMO
Daniel Brennan
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/20/26
Analysts' Top Healthcare Picks: Thermo Fisher (TMO), Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:IMR)
RBC Capital Analyst forecast on TMO
Dan Leonard
RBC Capital
RBC Capital
$490
Hold
-6.95%
Downside
Initiated
05/14/26
Thermo Fisher resumed with a Sector Perform at RBC CapitalThermo Fisher resumed with a Sector Perform at RBC Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on TMO
Brandon Couillard
Wells Fargo
Wells Fargo
$615
Buy
16.79%
Upside
Reiterated
07/14/26
Thermo Fisher (TMO) Gets a Buy from Wells Fargo
Morgan Stanley Analyst forecast on TMO
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$620
Buy
17.74%
Upside
Reiterated
07/10/26
Morgan Stanley Keeps Their Buy Rating on Thermo Fisher (TMO)
Deutsche Bank Analyst forecast on TMO
Justin Bowers
Deutsche Bank
Deutsche Bank
$630
Buy
19.64%
Upside
Reiterated
07/09/26
Thermo Fisher named short-term buy idea at Deutsche BankThermo Fisher named short-term buy idea at Deutsche Bank
Evercore ISI Analyst forecast on TMO
Vijay Kumar
Evercore ISI
Evercore ISI
$575→$570
Buy
8.24%
Upside
Reiterated
07/06/26
Thermo Fisher price target lowered to $570 from $575 at Evercore ISIThermo Fisher price target lowered to $570 from $575 at Evercore ISI
Bernstein Analyst forecast on TMO
Eve Burstein
Bernstein
Bernstein
$520
Hold
-1.25%
Downside
Initiated
06/25/26
Thermo Fisher resumed with a Market Perform at BernsteinThermo Fisher resumed with a Market Perform at Bernstein
Barclays Analyst forecast on TMO
Luke Sergott
Barclays
Barclays
$625
Buy
18.69%
Upside
Reiterated
06/24/26
Barclays Sticks to Their Buy Rating for Thermo Fisher (TMO)
William Blair Analyst forecast on TMO
Matt Larew
William Blair
William Blair
―
Buy
―
Reiterated
06/12/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Piper Sandler Analyst forecast on TMO
David Westenberg
Piper Sandler
Piper Sandler
$510
Hold
-3.15%
Downside
Initiated
06/11/26
Thermo Fisher initiated with a Neutral at Piper SandlerThermo Fisher initiated with a Neutral at Piper Sandler
HSBC Analyst forecast on TMO
Sidharth Sahoo
HSBC
HSBC
$670→$540
Hold
2.54%
Upside
Downgraded
06/03/26
Thermo Fisher downgraded to Hold from Buy at HSBCThermo Fisher downgraded to Hold from Buy at HSBC
Bank of America Securities Analyst forecast on TMO
Michael Ryskin
Bank of America Securities
Bank of America Securities
$630
Buy
19.64%
Upside
Reiterated
06/02/26
Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Thermo Fisher (NYSE: TMO)
Wolfe Research Analyst forecast on TMO
Michael Polark
Wolfe Research
Wolfe Research
$535
Buy
1.60%
Upside
Initiated
06/01/26
Thermo Fisher assumed with an Outperform at Wolfe ResearchThermo Fisher assumed with an Outperform at Wolfe Research
Jefferies Analyst forecast on TMO
Tycho Peterson
Jefferies
Jefferies
$650
Buy
23.43%
Upside
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), Thermo Fisher (NYSE: TMO) and Eli Lilly & Co (NYSE: LLY)
Stifel Nicolaus Analyst forecast on TMO
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$600
Buy
13.94%
Upside
Reiterated
05/21/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT), BioMarin Pharmaceutical (NASDAQ: BMRN) and Thermo Fisher (NYSE: TMO)
TD Cowen Analyst forecast on TMO
Daniel Brennan
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/20/26
Analysts' Top Healthcare Picks: Thermo Fisher (TMO), Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (AU:IMR)
RBC Capital Analyst forecast on TMO
Dan Leonard
RBC Capital
RBC Capital
$490
Hold
-6.95%
Downside
Initiated
05/14/26
Thermo Fisher resumed with a Sector Perform at RBC CapitalThermo Fisher resumed with a Sector Perform at RBC Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TARAProtara Therapeutics
BKDBrookdale Senior Living
EYPTEyePoint Pharmaceuticals
ZVRAZevra Therapeutics
DFTXDefinium Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Thermo Fisher

3 Months
Daniel AriasStifel Nicolaus
Success Rate
18/26 ratings generated profit
69%
Average Return
+2.62%
Copying Daniel Arias's trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +2.62% per trade.
1 Year
Sung Ji NamScotiabank
Success Rate
16/19 ratings generated profit
84%
Average Return
+16.18%
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +16.18% per trade.
2 Years
Sung Ji NamScotiabank
Success Rate
16/19 ratings generated profit
84%
Average Return
+32.41%
Copying Sung Ji Nam's trades and holding each position for 2 Years would result in 84.21% of your transactions generating a profit, with an average return of +32.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMO Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
20
22
28
30
18
Hold
1
1
3
6
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
23
31
36
23
In the current month, TMO has received 18 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. TMO average Analyst price target in the past 3 months is 587.44.
Each month's total comprises the sum of three months' worth of ratings.

TMO Financial Forecast

TMO Earnings Forecast

Next quarter’s earnings estimate for TMO is $5.72 with a range of $5.65 to $5.89. The previous quarter’s EPS was $5.44. TMO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.
Next quarter’s earnings estimate for TMO is $5.72 with a range of $5.65 to $5.89. The previous quarter’s EPS was $5.44. TMO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.

TMO Sales Forecast

Next quarter’s sales forecast for TMO is $11.71B with a range of $11.48B to $11.84B. The previous quarter’s sales results were $11.01B. TMO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.
Next quarter’s sales forecast for TMO is $11.71B with a range of $11.48B to $11.84B. The previous quarter’s sales results were $11.01B. TMO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year TMO has Performed in-line its overall industry.

TMO Stock Forecast FAQ

What is TMO’s average 12-month price target, according to analysts?
Based on analyst ratings, Thermo Fisher Scientific’s 12-month average price target is 587.44.
    What is TMO’s upside potential, based on the analysts’ average price target?
    Thermo Fisher Scientific has 11.55% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TMO a Buy, Sell or Hold?
          Thermo Fisher Scientific has a consensus rating of Strong Buy which is based on 16 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Thermo Fisher Scientific’s price target?
            The average price target for Thermo Fisher Scientific is 587.44. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $650.00 ,the lowest forecast is $490.00. The average price target represents 11.55% Increase from the current price of $526.6.
              What do analysts say about Thermo Fisher Scientific?
              Thermo Fisher Scientific’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
                How can I buy shares of TMO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.